Rimonabant: From RIO to Ban

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Sam, Amir H ^a   Salem, Victoria ^a   Ghatei, Mohammad A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856843131     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/432607     Document Type: Article

References (21)

1. Kim J., Isokawa M., Ledent C., Alger B. E., Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. Journal of Neuroscience 2002 22 23 10182 10191 2-s2.0-0036895968 (Pubitemid 35416857)
2. Munro S., Thomas K. L., Abu-Shaar M., Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993 365 6441 61 65 2-s2.0-0027515373 10.1038/365061a0 (Pubitemid 23305569)
3. De Vries T. J., Homberg J. R., Binnekade R., Raasø H., Schoffelmeer A. N. M., Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology 2003 168 1-2 164 169 2-s2.0-0037825704 10.1007/s00213-003- 1422-1 (Pubitemid 36851175)
4. Thanos P. K., Dimitrakakis E. S., Rice O., Gifford A., Volkow N. D., Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behavioural Brain Research 2005 164 2 206 213 2-s2.0-25144523091 10.1016/j.bbr.2005.06.021 (Pubitemid 41337875)
5. Navarro M., Hernández E., Muñoz R. M., Del Arco I., Villanúa M. A., Carrera M. R. A., Rodríguez De Fonseca F., Acute administration of the CB cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. NeuroReport 1997 8 2 491 496 2-s2.0-0030609879 (Pubitemid 27180108)
6. Di Marzo V., Goparaju S. K., Wang L., Liu J., Bátkai S., Járai Z., Fezza F., Miura G. I., Palmiter R. D., Sugiura T., Kunos G., Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001 410 6830 822 825 2-s2.0-0035848818 10.1038/35071088 (Pubitemid 32303781)
7. Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thöne-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A. C. E., Pasquali R., Lutz B., Stalla G. K., Pagotto U., The endogenous cennabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation 2003 112 3 423 431 2-s2.0-0041886785 10.1172/JCI200317725 (Pubitemid 38063771)
8. Tam J., Vemuri V. K., Liu J., Bátkai S., Mukhopadhyay B., Godlewski G., Osei-Hyiaman D., Ohnuma S., Ambudkar S. V., Pickel J., Makriyannis A., a.makriyannis@neu.edu Kunos G., gkunos@mail.nih.gov Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. Journal of Clinical Investigation 2010 120 8 2953 2966 10.1172/JCI42551
9. Van Gaal L. F., Rissanen A. M., Scheen A. J., Ziegler O., Rössner S., Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005 365 9468 1389 1397 2-s2.0-17144382751 10.1016/S0140-6736(05)66374-X (Pubitemid 40523733)
10. Després J. P., Golay A., Sjöström L., Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. New England Journal of Medicine 2005 353 20 2121 2134 2-s2.0-27844463517 10.1056/NEJMoa044537 (Pubitemid 41653104)
11. Pi-Sunyer F. X., Aronne L. J., Heshmati H. M., Devin J., Rosenstock J., Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients-RIO-North America: a randomized controlled trial. Journal of the American Medical Association 2006 295 7 761 775 2-s2.0-32644441249 10.1001/jama.295.7.761 (Pubitemid 43244304)
12. Scheen A. J., Finer N., Hollander P., Jensen M. D., Van Gaal L. F., Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006 368 9548 1660 1672 2-s2.0-33751001942 10.1016/S0140-6736(06)69571-8 (Pubitemid 46048528)
13. Rosenstock J., Hollander P., Chevalier S., Iranmanesh A., SERENADE: The study evaluating rimonabant efficacy in drug-naive diabetic patients: effects of monotherapy with rimonabant, the first selective CB receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. Diabetes Care 2008 31 11 2169 2176 2-s2.0-59049104050 10.2337/dc08-0386
14. Curioni C., André C., Rimonabant for overweight or obesity. Cochrane Database of Systematic Reviews 2006 4 2-s2.0-42749107961 10.1002/14651858.CD006162.pub2 CD006162 (Pubitemid 46841310)
15. Christensen R., Kristensen P. K., Bartels E. M., Bliddal H., Astrup A., Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007 370 9600 1706 1713 2-s2.0-36048995288 10.1016/S0140-6736(07)61721-8 (Pubitemid 350100788)
16. http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-fda- backgrounder.pdf, 2011
17. http://www.cdc.gov/obesity/causes/economics.html, 2011
18. Wang Y., Beydoun M. A., Liang L., Caballero B., Kumanyika S. K., Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008 16 10 2323 2330 2-s2.0-53849092685 10.1038/oby.2008.351
19. Olshansky S. J., Passaro D. J., Hershow R. C., Layden J., Carnes B. A., Brody J., Hayflick L., Butler R. N., Allison D. B., Ludwig D. S., A potential decline in life expectancy in the United States in the 21st century. New England Journal of Medicine 2005 352 11 1138 1145 2-s2.0-20144363712 10.1056/NEJMsr043743 (Pubitemid 40365358)
20. James W. P. T., jeanhjames@aol.com Caterson I. D., Coutinho W., Finer N., Van Gaal L. F., Maggioni A. P., Torp-Pedersen C., Sharma A. M., Shepherd G. M., Rode R. A., Renz C. L., Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. New England Journal of Medicine 2010 363 10 905 917 10.1056/NEJMoa1003114
21. http://www.tesofensine-information.com/qnexa.html, 2011